Avanos Bundle

What is the Sales and Marketing Strategy of Avanos Medical?
Avanos Medical is strategically shifting towards direct sales for key products, aiming to build stronger customer relationships and increase market share. This transformation is evident in their recent move to take direct control of MIC-KEY enteral feeding products in the UK.

This strategic pivot reflects a broader evolution for Avanos, moving from a diversified company to a focused medical device provider. Their sales and marketing efforts are now concentrated on highlighting clinically superior solutions in specific health areas.
Avanos Medical's sales and marketing strategy centers on a direct-to-customer approach for its core offerings. The company reported full-year 2024 sales of $688 million and anticipates 2025 revenue between $665 million and $685 million. This strategy aims to enhance market penetration and customer engagement for products like those in digestive health, as detailed in the Avanos PESTEL Analysis.
How Does Avanos Reach Its Customers?
Avanos Medical employs a strategic blend of direct sales and third-party distribution to reach its diverse customer base. This dual approach allows for deep engagement with key healthcare institutions while simultaneously expanding market reach through established networks.
Avanos directly engages with hospitals and other healthcare facilities. This channel is crucial for managing the sales of complex medical devices, ensuring specialized support and fostering strong client relationships.
The company also utilizes third-party wholesale distributors across the globe. This strategy broadens market penetration and ensures wider availability of its product portfolio.
Avanos's 2023-2025 transformation plan prioritizes 'strategic and commercial optimization,' placing customers at the forefront. This includes initiatives to enhance direct customer engagement and streamline distribution.
Effective July 25, 2025, Avanos took direct control of sales and distribution for its MIC-KEY enteral feeding products in the United Kingdom. This move concludes a 29-year partnership and aims to strengthen direct relationships with healthcare professionals and patients.
The company's Specialty Nutrition Systems (SNS) segment, including enteral feeding, saw robust growth with 8.7% volume increase in Q1 2025 and nearly 12% organic growth in Q4 2024. This growth is attributed to ENFit conversions and international OEM partnerships. Conversely, the Pain Management and Recovery (PM&R) segment experienced a 3% decline in normalized organic sales in Q4 2024, partly due to pricing pressures on its Hyaluronic Acid (HA) portfolio, which was divested on July 31, 2025. These strategic adjustments, including going direct in certain markets, reflect an ongoing effort to optimize the Avanos sales strategy for higher-growth areas and improved margins, aligning with their overall Avanos business strategy.
- Specialty Nutrition Systems (SNS) segment showed strong performance.
- Pain Management and Recovery (PM&R) segment faced challenges leading to divestiture.
- Direct control of UK MIC-KEY sales aims to enhance customer relationships.
- Strategic optimization is a core component of the Avanos marketing strategy.
- Understanding these channels is key to grasping the Competitors Landscape of Avanos.
Avanos SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format

What Marketing Tactics Does Avanos Use?
Avanos Medical's marketing tactics are designed to build awareness and generate leads within the healthcare sector, focusing heavily on digital engagement and direct interaction with healthcare professionals. The company's 2023-2025 transformation plan emphasizes 'commercial optimization' to deepen customer relationships.
Avanos is developing essential digital sales tools to enhance its commercial operations. These tools are crucial for providing accessible information and support to healthcare providers.
The company utilizes its corporate website and investor relations platforms for transparent communication. This ensures stakeholders have access to up-to-date information regarding the company's performance and strategy.
A foundational element of Avanos's strategy is data-driven marketing and customer segmentation. This approach aims to anticipate and meet customer needs effectively.
Content marketing, including clinical studies and white papers, is vital for educating healthcare providers. This highlights the clinically superior nature of their solutions.
Avanos actively participates in key industry events and conferences. These platforms facilitate networking, product showcasing, and thought leadership within the healthcare sector.
The company maintains a presence on professional social media platforms. This is likely used for corporate branding, recruitment, and disseminating industry news.
Avanos's marketing mix has evolved with a continuous focus on optimizing its commercial organization and investing in innovation. This includes a strategic review to align core product segments with product brands and revitalize global branding systems. The company is committed to customer education programs, reinforcing its role as a trusted partner for both patients and healthcare providers. This comprehensive approach supports the overall Avanos sales strategy and Avanos marketing strategy, contributing to Avanos company growth. For a deeper understanding of their market positioning, you can explore the Marketing Strategy of Avanos.
Avanos's business strategy involves a multi-faceted approach to reach its target audience and drive sales. The company's commitment to commercial optimization is a key driver for its sales and marketing efforts.
- Developing digital sales tools to improve efficiency and customer interaction.
- Leveraging corporate website and investor relations for transparent communication.
- Employing data-driven marketing and customer segmentation for personalized outreach.
- Creating educational content such as clinical studies and white papers.
- Participating in major industry events and conferences for networking and product visibility.
- Maintaining a professional social media presence for branding and industry engagement.
- Focusing on customer education programs to build trust and partnerships.
Avanos PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable

How Is Avanos Positioned in the Market?
Avanos Medical's brand positioning centers on delivering clinically superior solutions that help patients return to their lives, emphasizing innovation and patient-centric outcomes. This core message differentiates the company in the medical technology sector.
The brand's name, derived from 'advanced' and 'innovation,' reflects a strategic focus on rapid innovation for improved patient outcomes. This commitment is central to the Avanos sales strategy.
Avanos appeals to healthcare providers and patients by offering pioneering pain management and chronic care therapies that aim to reduce opioid reliance. This focus highlights the Avanos marketing strategy for healthcare.
Following its rebranding from Halyard Health in 2018, Avanos has maintained a visual identity and tone of voice that convey reliability and expertise. This consistent approach supports the Avanos company sales and marketing approach.
The company's 2024 Corporate Citizenship Report underscores its dedication to ethical decision-making and compliance, reinforcing its reputation and trustworthiness within the healthcare industry, a key aspect of Avanos healthcare marketing.
Avanos's brand positioning is further solidified by its emphasis on vital nutrition solutions that aid patient recovery, positioning it as a provider of value and clinically proven efficacy. Understanding the Target Market of Avanos is crucial for appreciating how these elements contribute to its overall business strategy.
A key differentiator in Avanos's brand positioning is its focus on therapies that offer alternatives to opioid use for pain management. This directly addresses a significant healthcare challenge.
The company's nutrition solutions are positioned to support patients transitioning from hospital care to home recovery. This highlights the breadth of its patient-focused offerings.
The company's name itself signifies a commitment to advancing medical solutions quickly, a core tenet of its Avanos business strategy and product launch marketing plan.
Avanos actively works to maintain brand consistency across its global operations, aligning product segments with their respective brands and revitalizing branding systems to support Avanos company growth.
The brand's communication emphasizes clinically proven results and value, which is essential for how Avanos market its medical devices and supports its Avanos medical sales efforts.
By highlighting ethical practices and compliance, Avanos builds trust with healthcare providers, patients, and regulatory bodies, a crucial element of its Avanos B2B marketing strategy healthcare.
Avanos Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout

What Are Avanos’s Most Notable Campaigns?
Avanos Medical's sales and marketing strategy is characterized by key campaigns focused on market expansion, portfolio optimization, and enhanced customer engagement. These initiatives are designed to drive the company's overall business strategy and strengthen its position in the competitive medical technology landscape.
A significant campaign involves Avanos taking over direct sales and distribution for its MIC-KEY enteral feeding products in the United Kingdom starting July 25, 2025. This move aims to foster stronger relationships with healthcare professionals and patients.
The company is actively transforming its portfolio through strategic divestitures and new product introductions. This includes the sale of its Respiratory Health business in early 2025 and the divestiture of Hyaluronic Acid product lines on July 31, 2025.
In November 2024, Avanos launched the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This launch is part of an effort to bolster its digestive health offerings and enhance its product portfolio.
Avanos is engaged in federal lobbying, notably supporting the NOPAIN Act in 2024. This advocacy aims to secure separate payment for its ON-Q and ambIT infusion pumps, effective January 1, 2025, improving market access for its non-opioid pain solutions.
These strategic campaigns underscore Avanos' commitment to refining its market approach and product focus, aligning with its broader business strategy for sustainable growth and improved financial performance. The company's efforts in market penetration and customer acquisition are evident through these targeted initiatives.
Divestitures, such as the HA product lines, are strategic moves to eliminate growth constraints and concentrate on higher-growth, higher-margin areas like Specialty Nutrition Systems and Pain Management & Recovery.
The shift to direct operations in the UK for MIC-KEY products is a key element of the Avanos sales strategy, aiming to enhance product availability and capture full margins by managing sales and distribution internally.
The company's marketing strategy for pain management products is supported by its advocacy for the NOPAIN Act, which will improve reimbursement for its infusion pumps, thereby driving adoption of its non-opioid solutions.
Bringing sales and distribution in-house for key product lines, like the MIC-KEY products in the UK, is a significant commercial optimization effort within Avanos's 2023-2025 transformation plan.
Avanos's B2B marketing strategy in healthcare involves direct engagement with healthcare professionals, product launches, and market access initiatives to ensure its medical devices are effectively utilized and reimbursed.
The transition from a long-standing distribution partnership to direct operations highlights Avanos's evolving sales channels and its proactive approach to managing its market presence, as detailed in the Brief History of Avanos.
Avanos Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked

- What is Brief History of Avanos Company?
- What is Competitive Landscape of Avanos Company?
- What is Growth Strategy and Future Prospects of Avanos Company?
- How Does Avanos Company Work?
- What are Mission Vision & Core Values of Avanos Company?
- Who Owns Avanos Company?
- What is Customer Demographics and Target Market of Avanos Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.